Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Hepatology

• Publication date

  1992-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/hep.1840150409PMID 1551637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current concepts. Primary sclerosing cholangitis.

  1994cited by this paper
• Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

  1991cited by this paper
• Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.

  1991cited by this paper
• Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes

  1990cited by this paper
• Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.

  1990cited by this paper
• Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

  1990cited by this paper
• Tauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine.

  1990cited by this paper
• Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration

  1990cited by this paper
• Ursodeoxycholic acid–induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

  1990cited by this paper
• Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis

  1989cited by this paper
• Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.

  1989cited by this paper
• Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.

  1989cited by this paper
• Effects of cholecystectomy on the kinetics of primary and secondary bile acids.

  1989cited by this paper
• No decrease in duodenal ulcer surgery after cimetidine in Hong Kong.

  1988cited by this paper
• Ursodeoxycholic acid for chronic liver diseases.

  1988cited by this paper
• Regulation of bile acid synthesis. II. Effect of bile acid feeding on enzymes regulating hepatic cholesterol and bile acid synthesis in the rat

  1988cited by this paper
• Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

  1987cited by this paper
• Simultaneous determination of pool sizes and fractional turnover rates, of deoxycholic acid, cholic acid and chenodeoxycholic acid in man by isotope dilution with 2H and 13C labels and serum sampling.

  1987cited by this paper
• Primary biliary cirrhosis.

  1987cited by this paper
• Serum bile acids. Physiological determinants and results in liver disease.

  1986cited by this paper
• Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.

  1984cited by this paper
• Current concepts in primary sclerosing cholangitis.

  1984cited by this paper
• Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates in human serum using 13C-labeled bile acids.

  1984cited by this paper
• Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles

  1984cited by this paper
• Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones

  1984cited by this paper
• Formation of ursodeoxycholic acid from chenodeoxycholic acid in the human colon: studies of the role of 7-ketolithocholic acid as an intermediate.

  1983cited by this paper
• Serum bile acid analysis.

  1983cited by this paper
• Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.

  1983cited by this paper
• Degradation of steroids in the human gut.

  1983cited by this paper
• A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges.

  1982cited by this paper
• Effect of 7-ketolithocholic acid on bile acid metabolism in humans.

  1982cited by this paper
• Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.

  1980cited by this paper
• Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acids.

  1980cited by this paper
• Effect of Ursodeoxycholic Acid (UDCA) on Primary Bile Acid Kinetics in Gallstone Patients

  1980cited by this paper
• Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients

  1979cited by this paper
• Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria.

  1979cited by this paper
• Pharmacology of chenodeoxycholic acid. II. Absorption and metabolism.

  1977cited by this paper
• Pharmacology of Chenodeoxycholic Acid: II. Absorption and metabolism

  1977cited by this paper
• Synthesis of the specific monosulfates of cholic acid.

  1975cited by this paper
• Bile acid inhibition of intestinal anaerobic organisms.

  1975cited by this paper
• Measurement of bile and acid kinetics by isotope dilution in man.

  1974cited by this paper
• Mechanism of cholestasis.

  1972cited by this paper
• Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation.

  1972cited by this paper
• Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction.

  1972cited by this paper
• Quantitative estimation os bile salts in serum.

  1970cited by this paper
• Kinetics of aquation of the fluoropentaamminecobalt(III) ion

  1970cited by this paper
• [On serum bile acids].

  1969cited by this paper
• A modified gas-liquid chromatographic procedure for the rapid determination of bile acids in biological fluids.

  1969cited by this paper
• The turnover of cholic acid in man: bile acids and steroids.

  1957cited by this paper

• History and prospects of bile acid therapies.

  2025cites this paper
• Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts

  2023cites this paper
• High-fat diets enhance and delay ursodeoxycholic acid absorption but elevate circulating hydrophobic bile salts

  2023cites this paper
• Current and emerging adjuvant therapies in biliary atresia

  2022cites this paper
• Mechanisms of pruritus in cholestasis: understanding and treating the itch

  2022cites this paper
• The Role of CYP3A in Health and Disease

  2022cites this paper
• Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis

  2022cites this paper
• Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction

  2021cites this paper
• Cholestasis-Associated Pruritus and Its Pruritogens

  2021cites this paper
• Role of bile acids in inflammatory liver diseases

  2021cites this paper
• Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies

  2020cites this paper
• UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.

  2019cites this paper
• A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 Patients

  2019cites this paper
• ChapTEr 5 URSODEOXYCHOLIC ACID MODULATES BILE FLOW AND BILE SALT POOL INDEPENDENTLY OF THE CYSTIC FIBROSIS TRANSMEMBRANE REGULATORY GENE IN MICE

  2018cites this paper
• A physiology-based model of bile acid metabolism shows altered tissue concentrations after drug administration and in specific genotype subgroups

  2018cites this paper
• EASL Recognition Award Recipient 2017: Prof. Gustav Paumgartner.

  2017cites this paper
• Ursodeoxycholic Acid for the Treatment of Liver Diseases

  2017cites this paper
• Autoimmune Liver Diseases: Primary Biliary Cholangitis

  2017cites this paper
• ABC Transporters Involved in Cholestasis

  2017cites this paper
• CAN URSODEOXYCHOLİC ACİD BE AN ALTERNATİVE OF N-ACETYLCYSTEİN İN ACUTE ACETAMİNOPHEN İNTOXİCATİON ?

  2016cites this paper
• Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders

  2016cites this paper
• [Ursodeoxycholic acid: A therapeutic niche in an internist's practice].

  2015cites this paper
• Pathogenesis and Management of Pruritus in PBC and PSC

  2015cites this paper
• New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.

  2015cites this paper
• Treatment of primary biliary cirrhosis

  2014cites this paper
• Advances in Pathogenesis and Management of Pruritus in Cholestasis

  2014cites this paper
• URSODEOXYCHOLATE MODULATES BILE FLOW AND BILE SALT POOL INDEPENDENTLY FROM CFTR IN MICE

  2014cites this paper
• Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis

  2014cites this paper
• Autophagy – another piece of the puzzle towards understanding primary biliary cirrhosis?

  2014cites this paper
• An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

  2014cites this paper
• Pruritus in cholestasis: Facts and fiction

  2014cites this paper
• Cystic fibrosis liver disease and the enterohepatic circulation of bile acids

  2014cites this paper
• Identification of a primary biliary cirrhosis associated protein as lysosome-associated membrane protein-2.

  2013cites this paper
• Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.

  2012cites this paper
• The Use of Stable and Radioactive Sterol Tracers as a Tool to Investigate Cholesterol Degradation to Bile Acids in Humans in Vivo

  2012cites this paper
• Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.

  2012cites this paper
• Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.

  2011cites this paper
• Cystic Fibrosis and the gastro-intestinal tract

  2011cites this paper
• Pharmacotherapy of cholestatic liver diseases

  2010cites this paper
• Learning from the pregnane X receptor: how to fight one aggressor with two strategies

  2010cites this paper
• Biliary physiology and disease: Reflections of a physician‐scientist

  2010cites this paper
• Progressive familial intrahepatic cholestasis : Clinical, biochemical, genetic and histopathological aspects

  2009cites this paper
• Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers

  2009cites this paper
• More right-sided IBD-associated colorectal cancer In patients with primary sclerosing cholangitis

  2009cites this paper
• Developments in bile acid kinetic measurements using 13C and 2H: 105 times improved sensitivity during the last 40 years

  2009cites this paper
• More right‐sided IBD‐associated colorectal cancer in patients with primary sclerosing cholangitis

  2008cites this paper
• Removal of Bile Acids by Two Different Extracorporeal Liver Support Systems in Acute-on-Chronic Liver Failure

  2007cites this paper
• Current treatments of primary sclerosing cholangitis.

  2007cites this paper
• Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.

  2007cites this paper
• Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis

  2006cites this paper
• Primary sclerosing cholangitis: updates in diagnosis and therapy.

  2005cites this paper
• Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines.

  2005cites this paper
• Metabolic, antioxidant, nutraceutical, probiotic, and herbal therapies relating to the management of hepatobiliary disorders.

  2004cites this paper
• Extracorporeal Albumin Dialysis in a Patient with Primary Sclerosing Cholangitis: Effect on Pruritus and Bile Acid Profile

  2004cites this paper
• Does Ursodeoxycholic Acid Change the Proliferation of the Colorectal Mucosa?

  2004cites this paper
• Current management of primary biliary cirrhosis and primary sclerosing cholangitis.

  2003cites this paper
• [Treatment of cholestatic liver diseases].

  2002cites this paper
• Tauroursodeoxycholic acid mobilizes α‐PKC after uptake in human HepG2 hepatoma cells

  2002cites this paper
• Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

  2001cites this paper
• Kinetics of Primary Bile Acids in Patients after Proctocolectomy and Ileal Pouch-Anal Anastomosis

  2001cites this paper
• Use of ursodeoxycholic acid in liver diseases

  2001cites this paper
• Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?

  2001cites this paper
• Effect of ursodeoxycholate in University of Wisconsin solution on long term preservation of rat livers.

  2001cites this paper
• Bile acids and progesterone metabolites intrahepatic cholestasis of pregnancy

  2000cites this paper
• [Evidence of daily stability of fasting serum bile acid levels in healthy volunteers].

  2000cites this paper
• Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study

  1999cites this paper
• Management of patients with primary biliary cirrhosis: a practical guide.

  1999cites this paper
• One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation.

  1999cites this paper
• Tauroursodeoxycholate ameliorates reperfusion injury after pig liver transplantation

  1999cites this paper
• Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

  1999cites this paper
• Management of Patients with Primary Biliary Cirrhosis

  1999cites this paper
• I reperfusion injury after pig liver transplantation

  1999cites this paper
• Colangitis esclerosante primaria

  1999cites this paper
• Tauroursodeoxycholate and S‐adenosyl‐L‐methionine exert an additive ameliorating effect on taurolithocholate‐induced cholestasis: A study in isolated rat hepatocyte couplets

  1999cites this paper
• Colonic mucosal proliferation is related to serum deoxycholic acid levels

  1999cites this paper
• In vivo protection of the pig liver against ischemia/reperfusion injury by tauroursodeoxycholate

  1999cites this paper
• Bile acid abnormalities in cholestatic liver diseases.

  1999cites this paper
• Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications

  1998cites this paper
• Infusion of hydrophilic bile salts protects the liver from reperfusion injury in the rat.

  1997cites this paper
• Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients

  1997cites this paper
• Donor pretreatment with hydrophilic bile salts protects the liver from preservation and reperfusion injury in the rat.

  1997cites this paper
• Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene

  1997cites this paper
• Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo.

  1997cites this paper
• Increased intercellular adhesion molecule-1 serum concentration in cholestasis.

  1996cites this paper
• Cytotoxic and Protective Effects of Bile Salts in Vitro

  1996cites this paper
• Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.

  1996cites this paper
• Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.

  1996cites this paper
• Clinical Pharmacokinetics of Therapeutic Bile Acids

  1996cites this paper
• Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes.

  1996cites this paper
• Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease

  1996cites this paper
• Feedback regulation of bile acid synthesis measured by stable isotope kinetics in humans

  1996cites this paper
• Hepatic levels of bile acids in end-stage chronic cholestatic liver disease.

  1996cites this paper
• [Mechanism of action of ursodeoxycholic acid in cholestatic liver diseases].

  1996cites this paper
• Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.

  1995cites this paper
• Bile acids in the diagnosis, pathology, and therapy of hepatobiliary diseases.

  1995cites this paper
• Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.

  1995cites this paper
• Differential effect of ursodeoxycholate and its taurine conjugate on biliary transport maximum of bilirubin in the rat.

  1995cites this paper
• Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.

  1995cites this paper
• The ursodeoxycholic acid story in primary biliary cirrhosis.

  1995cites this paper
• Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

  1994cites this paper